Drug Approval | April 23, 2026
Cipla’s generic Ventolin HFA secures USFDA approval
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
The conclave brought together key stakeholders from across the assisted living ecosystem
The unit is equipped with advanced monitoring systems and supported by a multidisciplinary team
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
Subscribe To Our Newsletter & Stay Updated
